Similarly, Brazils ANVISA approved Mounjaro in Q1 2024, with Eli Lilly partnering with local distributors to accelerate patient access
More recently, Moldofsky published a brief review of the literature regarding sleep disorders and soft-tissue tender- ness.13 As a result of this research on sleep disorders and FMS, it was presumed that patients with FMS might show clinical improvement with respect to soft-tissue tenderness if the quality of their sleep was improved.9,10 This led to the prescription of low doses of various antidepressant medications in an effort to induce deeper sleep, which clinically seemed to help many patients with FMS (at least in the short term)
This is particularly relevant for patients on semaglutide, since GI AEs, such as nausea and bloating, might be aggravated by low-grade systemic inflammation [125]
"In 2023, it is estimated that 500,000 people consumed one of these drugs in the US, and it is estimated that it could reach up to 15 million American adults by 2030
Anticancer activities of mushrooms: a neglected source for drug discovery
Grip strength declining 38 kg from baseline often months before any change appears on a body composition scan
